Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hydrocarbon/neoplasms

Länken sparas på Urklipp
Sida 1 från 144 resultat

Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION This invention relates to novel bis[bis (diphenylphosphino)hydrocarbon]-, bis[bis(diethylphosphino)hydrocarbon]-, bis[diphenylphosphino-diethylphosphino)hydrocarbon]gold(I), silver(I) or copper(I) complexes or tris[bis(diphenylphosphino)ethane]dicopper (I) derivatives
BACKGROUND OF THE INVENTION This invention relates to novel .alpha.,.omega.-bis(disubstitutedphosphino)hydrocarbon compounds, digold(I), digold(III), disilver(I) or dicopper(I) complexes thereof, pharmaceutical compositions containing, as an active ingredient,

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 2, 2016 is named 701586-067982-US_SL.txt and is 8,192 bytes in size. FIELD OF THE

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 20, 2013 is named 701586-067982-US_SL.txt and is 8,192 bytes in size. FIELD OF THE

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 20, 2013 is named 701586-067982-US_SL.txt and is 8,192 bytes in size. FIELD OF THE

Compounds for treatment of cancer

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating various forms of cancer. BACKGROUND OF THE INVENTION Cancer is the second most common cause of death in the United States, exceeded only

Methods for preventing and treating cancer using N-thiolated .beta.-lactam compounds and analogs thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to N-thiolated .beta.-lactam compounds, and analogs and derivatives thereof, which potently induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation. Specifically, the invention relates to methods of treating conditions

Methods for preventing and treating cancer using N-thiolated .beta.-lactam compounds and analogs thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to N-thiolated .beta.-lactam compounds, and analogs and derivatives thereof, which potently induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation. Specifically, the invention relates to methods of treating conditions
BACKGROUND OF THE INVENTION This invention relates to novel [bis(diphenylphosphino)alkyl]bis-gold[I] derivatives which have tumor cell growth-inhibiting activity, pharmaceutical compositions containing such novel derivatives, and a method for treating tumor cells sensitive to such derivatives by

Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The invention is directed to novel synthetic C-glycolipids, which are useful in treating cancer, infectious diseases and autoimmune diseases. Specifically, the invention is directed to novel synthetic analogs of .alpha.-C-galactosylceramides, which are potent mediators of

Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The invention is directed to novel synthetic C-glycolipids, which are useful in treating cancer, infectious diseases and autoimmune diseases. Specifically, the invention is directed to novel synthetic analogs of .alpha.-C-galactosylceramides, which are potent mediators of

Antigenic conjugates of polycyclic aromatic hydrocarbons to nucleosides

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to novel immunologic reagents and their use in assays for the detection of polycyclic aromatic hydrocarbon (PAH)-DNA adducts as well as heteropolycyclic aromatic hydrocarbon (HAH)-DNA adducts. These adducts are uniquely important biomarkers for

Near-infrared super-continuum lasers for early detection of breast and other cancers

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application is related to U.S. provisional application Ser. No. 61/747,477 filed Dec. 31, 2012; Ser. No. 61/747,481 filed Dec. 31, 2012; Ser. No. 61/747,485 filed Dec. 31, 2012; Ser. No. 61/747,487 filed Dec. 31, 2012; Ser. No. 61/747,492 filed Dec. 31, 2012; Ser. No. 61/747,472 filed Dec. 31,

5'-deoxy-cytidine derivative administration to treat solid tumors

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention is concerned with novel 5'-deoxy-cytidine derivatives, pharmaceutical compositions, a kit thereof for assisting a delivery of 5-fluorouracil selectively to tumor tissues and process for manufacturing the novel 5'-deoxy-cytidine

Pharmaceutical composition for inhibiting the growth of viruses and cancers

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed. BACKGROUND OF THE INVENTION Cancers
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge